Too few people treated for hepatitis C

A new CDC Vital Signs report finds that too few people diagnosed with hepatitis C are being treated, despite availability of medications capable of curing this viral infection. According to […]

Firearm Deaths Grow, Disparities Widen

Firearms were involved in 79% of all homicides and 53% of all suicides in 2020. Against the backdrop of the COVID-19 pandemic, there has been a historic increase of 35% […]

Alert (AA22-103A)

Contact Information
All organizations should report incidents and anomalous activity to CISA 24/7 Operations Center at [email protected] or (888) 282-0870 and/or to the FBI via your local FBI field office or the FBI’s 24/7 CyWatch at (855) 292-3937 or [email protected] When available, please include the following information regarding the incident: date, time, and location of the incident; type of activity; number of people affected; type of equipment used for the activity; the name of the submitting company or organization; and a designated point of contact. For NSA client requirements or general cybersecurity inquiries, contact the Cybersecurity Requirements Center at 410-854-4200 or [email protected]

Sotrovimab Monoclonal Antibody Treatment for COVID-19

As of April 5, 2022, the U.S. Food and Drug Administration (FDA) reissued the emergency use authorization (EUA) for GSK-Vir Biotechnology’s sotrovimab monoclonal antibody treatment. It is important to note […]